Champlain Investment Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EQT Corp
EQT
|
+$20.9M |
| 2 |
DexCom
DXCM
|
+$17.9M |
| 3 |
Teradyne
TER
|
+$16.4M |
| 4 |
Snowflake
SNOW
|
+$12.1M |
| 5 |
iRhythm Holdings
IRTC
|
+$11.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aaon
AAON
|
+$145M |
| 2 |
Synopsys
SNPS
|
+$124M |
| 3 |
Akamai
AKAM
|
+$118M |
| 4 |
Datadog
DDOG
|
+$117M |
| 5 |
Tradeweb Markets
TW
|
+$112M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 23.76% |
| 2 | Technology | 22.16% |
| 3 | Financials | 17.92% |
| 4 | Healthcare | 16.66% |
| 5 | Consumer Discretionary | 9.65% |
Similar funds
Champlain Investment Partners's Q2 2026 Portfolio in Review
As of Q2 2026, Champlain Investment Partners held 137 positions worth $3.89B, down 51% from $7.88B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Champlain Investment Partners withdrew a net $4.73B in Q2 2026, closing 8 positions and reducing 115 holdings. Its most notable exit was Hamilton Lane, an estimated $108M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 24% of assets, down from 25% a quarter earlier, followed by Technology and Financials.
Against the trend, Champlain Investment Partners opened a new position in EQT Corp worth $19.8M.
- Champlain Investment Partners's largest Q2 2026 buy was EQT Corp: 371,955 shares worth $19.8M.
- Champlain Investment Partners added most to Merit Medical Systems in Q2 2026, an estimated $7.48M increase.
- Champlain Investment Partners's biggest Q2 2026 reduction was Aaon, cutting an estimated $145M.
- Champlain Investment Partners fully exited Hamilton Lane in Q2 2026, selling an estimated $108M.
- Champlain Investment Partners's ten largest holdings make up 18% of its $3.89B portfolio in Q2 2026.
- Champlain Investment Partners opened 7 new positions and closed 8 in Q2 2026.
- Champlain Investment Partners's portfolio value fell 51% quarter-over-quarter to $3.89B.
Based on Champlain Investment Partners's 13F filing for Q2 2026, filed 12 Aug 2026.